Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
After finishing at $5.92 in the prior trading day, CERo Therapeutics Holdings Inc (NASDAQ: CERO) closed at $4.68, down -20.95%. In other words, the price has decreased by -$20.95 from its previous closing price. On the day, 0.57 million shares were traded. CERO stock price reached its highest trading level at $6.0946 during the session, while it also had its lowest trading level at $4.2701.
Ratios:
Our goal is to gain a better understanding of CERO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.56 and its Current Ratio is at 0.56.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 13 ’24 when YK Bioventures Opportunities G sold 2,998,908 shares for $0.06 per share. The transaction valued at 179,934 led to the insider holds 13,005,169 shares of the business.
YK Bioventures Opportunities G sold 1,614,541 shares of CERO for $113,018 on Dec 12 ’24. The 10% Owner now owns 16,004,077 shares after completing the transaction at $0.07 per share. On Dec 11 ’24, another insider, YK Bioventures Opportunities G, who serves as the 10% Owner of the company, sold 1,343,801 shares for $0.08 each. As a result, the insider received 107,504 and left with 17,618,618 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CERO now has a Market Capitalization of 5641272 and an Enterprise Value of 12065655.
Stock Price History:
The Beta on a monthly basis for CERO is 0.50, which has changed by -0.97510636 over the last 52 weeks, in comparison to a change of 0.18189907 over the same period for the S&P500. Over the past 52 weeks, CERO has reached a high of $895.40, while it has fallen to a 52-week low of $5.41. The 50-Day Moving Average of the stock is -42.12%, while the 200-Day Moving Average is calculated to be -91.59%.
Shares Statistics:
The stock has traded on average 1.18M shares per day over the past 3-months and 546680 shares per day over the last 10 days, according to various share statistics. A total of 1.19M shares are outstanding, with a floating share count of 1.14M. Insiders hold about 5.53% of the company’s shares, while institutions hold 18.61% stake in the company. Shares short for CERO as of 1755216000 were 35067 with a Short Ratio of 0.03, compared to 1752537600 on 16267. Therefore, it implies a Short% of Shares Outstanding of 35067 and a Short% of Float of 2.98.
Earnings Estimates
The current assessment of CERo Therapeutics Holdings Inc (CERO) involves the perspectives of 1 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$1.7, with high estimates of -$1.7 and low estimates of -$1.7.
Analysts are recommending an EPS of between -$15.39 and -$15.39 for the fiscal current year, implying an average EPS of -$15.39. EPS for the following year is -$3.7, with 1.0 analysts recommending between -$3.7 and -$3.7.
